局部电泳给药诱导长期突触抑制的方法

Borys Olifirov; Oleksandra Fedchenko; Alexandr Dovgan; Daria Babets; Volodymyr Krotov; Volodymyr Cherkas; Pavel Belan

doi:10.21769/BioProtoc.5338

Improve Research Reproducibility A Bio-protocol resource

提交稿件
订阅
登录
/
注册
- 个人主页
- 编辑个人信息
- 修改密码
- 退出
CN
- EN - English
- CN - 中文

Peer-reviewed

Local Iontophoretic Application for Pharmacological Induction of Long-Term Synaptic Depression

局部电泳给药诱导长期突触抑制的方法

Borys Olifirov ^§

OF Oleksandra Fedchenko

PB Pavel Belan email

(§Technical contact: bolifirov@biph.kiev.ua) 发布: 2025年06月05日第15卷第11期 DOI: 10.21769/BioProtoc.5338 浏览次数: 2131

评审: Anonymous reviewer(s)

PDF

Q&A

引用

Cited by

参见作者原研究论文

The authors used this protocol in:

Cover of European Journal of Neuroscience, featuring study using the protocol.

Aug 2010

Special Issue on Protocols for Organoid Research

实验方案合集

Cell Imaging - A Special Collection for Cell Bio 2023

相关实验方案

利用Ca²⁺成像技术鉴定含钙通透性AMPA受体和海藻酸受体的神经元

Sergei G. Gaidin [...] Sultan T. Tuleukhanov

2025年02月05日 1961 阅读

AMPA受体囊泡的单粒子追踪研究

Victor C. Wong [...] Erin K. O’Shea

2025年06月05日 2547 阅读

用于冷冻电子断层成像分析的大鼠脑突触末端超快速分离

Rong Sun and Qiangjun Zhou

2025年09月05日 3800 阅读

Abstract

Long-term depression (LTD), a key form of synaptic plasticity, is typically induced through regulated Ca²⁺ entry via NMDA receptors and achieved by prolonged (up to hundreds of seconds) low-frequency presynaptic stimulation or bath application of NMDA receptor agonists. Electrophysiological approach to LTD induction requires specialized equipment, while bath applications limit productivity, as only one neuron per sample may be recorded. Here, we present a simple and effective protocol for pharmacological modeling of LTD in primary cultured neurons. This approach relies on highly localized iontophoretic application of NMDA, which induces LTD in individual cells, enhancing experimental throughput. We have analyzed spatio-temporal patterns of iontophoretic drug delivery and demonstrated how this technique may be combined with electrophysiological and live-cell imaging approaches to investigate LTD-related changes in synaptic strength and Ca²⁺-dependent signaling of neuronal Ca²⁺ sensor proteins.

Key features

• Easy, fast, and reliable induction of LTD in primary cultured neurons using iontophoretic NMDA application.

• Suitable for the application of any ionic water-soluble compound and compatible with simultaneous multicolor fluorescence imaging and electrophysiological recording.

• This protocol enables pharmacological targeting of individual neurons, substantially increasing experimental throughput.

Keywords: Calcium (钙信号)

Long-term plasticity (长期可塑性)

Chemical LTD (化学性LTD)

Live-cell imaging (活细胞成像)

Image processing (图像处理)

Patch clamp recordings (膜片钳记录)

Graphical overview

Local iontophoretic application of NMDA, combined with patch-clamp recording of miniature excitatory postsynaptic current (mEPSC) and live-cell fluorescence imaging

Background

Long-term depression (LTD) is an activity-dependent reduction of synaptic strength that is considered to mediate important brain functions such as learning and memory [1–3]. Despite several decades of research, the exact mechanisms of LTD induction and maintenance remain largely elusive. To boost their investigation, easy and reliable methods for eliciting LTD are required. Currently, LTD induction is achieved through either an electrophysiological or pharmacological approach. Both approaches cause a prolonged elevation (lasting up to several hundred seconds) in intracellular free calcium ion concentration ([Ca²⁺]_i), leading to AMPA receptor internalization [3,4]. Electrophysiologically, LTD may be modeled by performing low-frequency stimulation (1 Hz for 200–300 s) of afferent fibers or presynaptic neurons and holding postsynaptic neurons at -40 mV to relieve the Mg²⁺ block on NMDA receptors (NMDARs) [5–8]. This method requires specialized equipment as well as prior identification of monosynaptically connected neurons, which can be challenging when working with primary cultures. The pharmacological approach to LTD induction is simpler and involves bath application of NMDA (20–50 μM) in the presence of NMDA receptor coactivator glycine (10–20 μM) [6,8–12]. Yet, bath application creates an unpredictable spatio-temporal profile of NMDA concentration and affects all cells in the sample, limiting recordings to a single neuron per sample. To circumvent the drawbacks of previously developed protocols and increase experimental throughput, LTD induction may be accomplished with iontophoresis, a method for rapid and localized drug delivery that is widely used in pharmacological and biophysical studies [13–16]. However, the potential use of iontophoretic application for LTD induction has never been explored.

Here, we provide a detailed protocol of iontophoretic NMDA application for LTD induction in primary cultured hippocampal neurons and describe how it may be coupled with electrophysiological recordings and multicolor epifluorescent imaging. To validate the new protocol, we showed that iontophoretic application of NMDA (100 mM in the electrode) for 1 min produced a long-lasting reduction in the amplitudes of miniature excitatory postsynaptic currents (mEPSCs) and elicited LTD-associated Ca²⁺-dependent translocation of hippocalcin (HPCA), a neuronal Ca²⁺ sensor protein, from the cytosol to the neuronal plasma membrane [17,18]. We have also demonstrated that the iontophoresis produced a highly localized concentration gradient, enabling pharmacological targeting of individual neurons. This feature provides a significant advantage over standard bath application, as it allows performing experiments on multiple cells within a single coverslip. This is especially beneficial when working with transfected neurons, given the low success rate of exogenous expression.

It is worth noting that this protocol has great potential for modifications. First, short (up to 10 s) iontophoretic NMDA applications might be used to study various Ca²⁺-dependent processes. Second, this protocol may be modified to rapidly and locally apply any ionic water-soluble compounds, e.g., glycine or DHPG, to induce long-term potentiation or mGluR-dependent long-term depression of synaptic transmission, respectively [12,19]. Finally, this protocol may be easily combined with advanced microscopy techniques such as confocal [8,12], total internal reflection fluorescence (TIRF) [8–10], and stimulated emission depletion (STED) microscopy [12].

Materials and reagents

Biological materials

1. Primary neuronal culture DIV 10–20 (see [20,21] for hippocampal culture, see [21] for cortical culture)

2. Plasmids for transient transfection: HPCA-EYFP [17], PSD-95-pTagRFP (Addgene #52671)

Note: This protocol does not cover procedures for the cultivation and transient transfection of neurons.

Reagents

1. NaCl (MilliporeSigma, catalog number: S9625)

2. KCl (MilliporeSigma, catalog number: P3911)

3. CaCl₂ (MilliporeSigma, catalog number: C3881)

4. MgCl₂·6H₂O (MilliporeSigma, catalog number: M2670)

5. NaOH (MilliporeSigma, catalog number: S8045)

6. KOH (MilliporeSigma, catalog number: P1767)

7. Methanesulfonic acid (MilliporeSigma, catalog number: 47356)

8. Magnesium ATP (MilliporeSigma, catalog number: A9187)

9. Sodium GTP (MilliporeSigma, catalog number: G8877)

10. Disodium phosphocreatine (MilliporeSigma, catalog number: P7936)

11. EGTA (MilliporeSigma, catalog number: E0396)

12. HEPES (MilliporeSigma, catalog number: H7523)

13. Glucose (MilliporeSigma, catalog number: G7528)

14. Anhydrous DMSO (MilliporeSigma, catalog number: D2650)

15. NMDA (MilliporeSigma, catalog number: M3262)

16. Glycine (MilliporeSigma, catalog number: G7126)

17. Tetrodotoxin citrate (TTX) (Tocris, catalog number: 1069); prepare 5 mM stock solution according to manufacturer protocol

18. Alexa Fluor 594 hydrazide (Thermo Fisher, catalog number: A10438)

19. Fluo-4/AM (Thermo Fisher, catalog number: F14201)

20. Ethanol, 96% v/v

Solutions

1. HEPES buffered saline (HBS) with 1 mM/0.3 mM Mg²⁺ (see Recipes)

2. KCl-methanesulfonate intracellular solution (see Recipes)

3. HEPES (0.5 M, pH 7.3, stock solution in ddH₂O) (see Recipes)

4. NMDA (100 mM, stock solution in 10 mM HEPES, pH 7.3) (see Recipes)

5. Glycine (100 mM, stock solution in 10 mM HEPES, pH 7.3) (see Recipes)

6. Alexa Fluor 594 (5 mM, stock solution in 10 mM HEPES, pH 7.3) (see Recipes)

7. Fluo-4/AM (5 mM, stock solution in DMSO) (see Recipes)

Recipes

A. Extracellular solution

Note: Alternative compositions for an extracellular solution only differ by the concentration of Mg²⁺, which is crucial for studying NMDAR-dependent signaling, so you could choose only one that is appropriate for the particular experimental design.

1. HEPES buffered saline (HBS) with 1 mM/0.3 mM Mg²⁺

Reagent	Final concentration	Quantity or volume
NaCl	150 mM	4,383 mg
KCl	2.5 mM	92.5 mg
CaCl₂	2 mM	147 mg
MgCl₂·6H₂O	1 mM/0.3 mM	102 mg/30.5 mg
HEPES	10 mM	1,192 mg
ddH₂O	n/a	500 mL

I = 160 mM, osmolarity ~290–310 mOsm/L.

Notes:

1. Dissolve all components in ~3/4 of the final volume, adjust pH to 7.3 with 2–3 M NaOH solution, and adjust the volume to the final value. Filter and store at 4 °C for no longer than 6 months.

2. Add glucose before the start of the experiment (9 mg per 10 mL of HBS).

B. Intracellular solution

2. KCl-methanesulfonate intracellular solution

Reagent	Final concentration	Quantity or volume
KCl	10 mM	18.64 mg
Methanesulfonic acid	135 mM	324.37 mg
Magnesium ATP	4 mM	50.7 mg
Sodium GTP	0.4 mM	5.23 mg
Disodium phosphocreatine	5 mM	31.89 mg
EGTA	0.5 mM	4.75 mg
HEPES	10 mM	59.5 mg
ddH₂O	n/a	25 mL

Osmolarity ~270–290 mOsm/L.

Note: Methanesulfonic acid is highly viscous; handle it carefully. The necessary volume is 219 μL (ρ = 1.481 g/mL). Dissolve all components in ~3/4 of the final volume, adjust pH to 7.3 with KOH, and adjust the volume to the final value. Make 0.5 mL aliquots and store at -20 °C for no longer than 12 months.

C. Pharmacological compounds and dyes

3. HEPES (0.5 M, pH 7.3, stock solution in ddH₂O)

Reagent	Final concentration	Quantity or volume
HEPES	0.5 M	2.979 mg
ddH₂O	n/a	25 mL

Note: Dissolve all components in ~3/4 of the final volume, adjust pH to 7.3 with 2–3 M NaOH solution, and adjust the volume to the final value. Filter and store at 4 °C. This stock buffer solution is used to dissolve pharmacological compounds and dyes.

4. NMDA (100 mM, stock solution in 10 mM HEPES, pH 7.3)

Reagent	Final concentration	Quantity or volume
NMDA	100 mM	7.36 mg
HEPES stock solution (Recipe 3)	10 mM	10 μL
ddH₂O	n/a	490 μL

Note: Given that it may be difficult to weigh small quantities of NMDA, weigh the compound directly in the 1.5 mL reaction tube, and use the following relationship to estimate the appropriate volume of stock solution components: 66.608 μL of ddH₂O and 1.359 μL of 0.5 M HEPES, pH 7.3 per1 mgof NMDA (MW = 147.13 g/mol). Add ddH₂O first, then the buffer stock solution; dissolve the compound with active tube agitation or vortexing. Briefly centrifuge the tube to collect all the solution at the bottom, aliquot it, and store at -20 °C for no longer than 6 months.

5. Glycine (100 mM, stock solution in 10 mM HEPES, pH 7.3)

Reagent	Final concentration	Quantity or volume
Glycine	100 mM	37.55 mg
HEPES stock solution (Recipe 3)	10 mM	0.1 mL
ddH₂O	n/a	4.9 mL

Note: Add ddH₂O first, then the buffer stock solution; dissolve the compound, aliquot it, and store at -20 °C for no longer than 10–12 months.

6. Alexa Fluor 594 (5 mM, stock solution in 10 mM HEPES, pH 7.3)

Reagent	Final concentration	Quantity or volume
Alexa Fluor 594	5 mM	1 mg
HEPES stock solution (Recipe 3)	10 mM	5.27 μL
ddH₂O	n/a	258.31 μL

Note: Volume estimated for 1 mg of dye (MW = 758.79 g/mol); add ddH₂O first, then the buffer stock solution, and dissolve the compound by shaking or vortexing. Briefly centrifuge the tube to collect all the solution at the bottom, aliquot it, and store at -20 °C no longer than 10–12 months.

7. Fluo-4/AM (5 mM, stock solution in DMSO)

Reagent	Final concentration	Quantity or volume
Fluo-4/AM	5 mM	50 μg
DMSO	n/a	9.12 μL

Note: Volume estimated for 50 μg of dye (MW = 1096.95 g/mol); add DMSO and dissolve the dye with gentle pipetting; use only anhydrous DMSO; the presence of H₂O in the solvent may dramatically affect dye solubility. Briefly centrifuge the tube, aliquot the solution, and store at -20 °C for no longer than 10–12 months. Try to reduce the number of freeze-thaw cycles of aliquots and check for the presence of precipitate before using. Pipette the solution if necessary.

Laboratory supplies

1. 35 mm Petri dish (CellStar, catalog number: 627160)

2. 1.5 mL reaction tube (Greiner, catalog number 616 201)

3. Glass capillaries with filament O.D. 1.5 mm, I.D. 0.86 mm (Sutter Instrument, catalog number: BF150-86-10)

4. 2.5 mm box-shaped heating filament for microelectrode puller (Sutter Instruments, catalog number: FB255B)

5. Tygon^® tube O.D. 2.4 mm I.D. 0.7 mm (Saint-Gobain, catalog number: B-44-4X)

6. Silicon tubing (VWR, catalog number: 228-0701)

7. Luer to tube assortment kit (WPI, catalog number: 504954)

8. Luer valve assortment kit (WPI, catalog number: 14011)

9. Luer-lock syringes (any available with a volume of 1, 10, and 20 mL)

10. Silicone grease (Warner Instruments, catalog number: W4 64-0275)

11. Cross-locking tweezer (Dumont, catalog number: 0202-N5-PS)

12. MicroFil flexible needle (WPI, catalog number: MF28G67-5)

13. Alcohol burner

Equipment

A. Imaging and electrophysiology

1. Inverted microscope (Olympus, model: IX71)

2. 40× oil-immersion high-aperture objective (Olympus, model: UApo/340 40×/1.35)

3. Optical filters set (suitable for selected fluorophores, in our case, Chroma, model: 69008)

4. Dual-view splitter (Optical Insights, model: MSMI-DV-FC)

5. Digital camera (PCO, model: SensiCam QE)

6. Vibration isolation table (CleanBench, model: TMC)

7. Imaging control unit (TILL Photonics, model: ICU2)

8. Monochromator (TILL Photonics, model: Polychrome V)

9. Patch clamp amplifier (HEKA, model: EPC 10)

10. Micromanipulators (Sutter Instrument, model: MPC-200)

11. Ag/AgCl pellets (WPI, catalog number: EP1)

12. Experimental chamber (Warner Instruments, model: RC-25 or DIY analog)

13. Microelectrode puller (Sutter Instrument, model: P-97)

14. BNC cables

15. Computer for setup control

16. Compact benchtop incubator (any capable of maintaining 37 °C, e.g., VWR, model: INCU-Line IL 10)

B. Gravity-fed perfusion system (optional)

17. Peristaltic pump (Kamoer, model: DIPump550)

18. Flow dial (Bioscience Tools, model: PS-FLOW)

19. Temperature controller (Warner Instruments, model: TC-344B)

20. In-line heater (Warner Instruments, model: SH-27B)

21. Magnetic clamp for outlet tube (Warner Instruments, model: MAG-2)

22. Valve controller (Bioscience Tools, model: cValve-6)

23. Solenoid valves (NResearch Inc., models: 161P021, 161P091)

Note: We validate our protocol in the presence and absence of continuous perfusion, but a closed-loop perfusion system is highly recommended for consistent washout kinetics and reproducibility. See the detailed description of the perfusion system in supplementary Figure S1 and Figure S2; 3D models of perfusion system parts for fused deposition modeling (FDM) printing can be provided upon request.

Software and datasets

A. Experimental setup control

1. PatchMaster (v2x69, HEKA, Germany)

2. Live Acquisition (v2.6.0.12, FEI, Germany)

B. mEPSC analysis

3. Clampfit (v11.3, Molecular Devices, USA)

4. NeuroExpress (v24.8.02, GitHub: github.com/attilaszuc/NeuroExpress-patch-clamp-analysis)

C. Image analysis

5. napari (v0.4.19) [22]

6. domb-napari plugin (v0.3.0) [23]

Procedure

English

中文翻译

文章信息

稿件历史记录

提交日期: Mar 31, 2025

接收日期: May 6, 2025

在线发布日期: May 27, 2025

出版日期: Jun 5, 2025

版权信息

如何引用

Olifirov, B., Fedchenko, O., Dovgan, A., Babets, D., Krotov, V., Cherkas, V. and Belan, P. (2025). Local Iontophoretic Application for Pharmacological Induction of Long-Term Synaptic Depression. Bio-protocol 15(11): e5338. DOI: 10.21769/BioProtoc.5338.